Search research articles
Contact Us
Filters
Showing results (201-210 of 221) with videos related to
Page
of 23
Sort By:
BMC Pulmonary Medicine
|
December 5, 2025
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)
Wim A Wuyts, Luca Richeldi, Shervin Assassi, et al.
The Journal of Allergy and Clinical Immunology
|
February 3, 2016
Variants near the HLA complex group 22 gene (HCG22) confer increased susceptibility to late-onset asthma in Japanese populations
Yohei Yatagai, Tomomitsu Hirota, Tohru Sakamoto, et al.
The European Respiratory Journal
|
August 7, 2025
Pulmonary Sarcoidosis Clinical Trial Endpoints: A Delphi Study
Robert P Baughman, Jan C Grutters, Elyse E Lower, et al.
The New England Journal of Medicine
|
May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
Toby M Maher, Shervin Assassi, Arata Azuma, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 16, 2015
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, et al.
The Lancet. Respiratory Medicine
|
January 7, 2021
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
Kristin B Highland, Oliver Distler, Masataka Kuwana, et al.
ERJ Open Research
|
June 5, 2020
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan
Yuji Minegishi, Akihiko Gemma, Sakae Homma, et al.
The New England Journal of Medicine
|
May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
Luca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
Respiratory Investigation
|
March 1, 2021
The Japanese respiratory society guidelines for the management of cough and sputum (digest edition)
Hiroshi Mukae, Takeshi Kaneko, Yasushi Obase, et al.
Respiratory Research
|
July 25, 2016
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study)
Takekazu Iwata, Ichiro Yoshino, Shigetoshi Yoshida, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 221) with videos related to
Sort By:
Page
of 23
BMC Pulmonary Medicine
|
December 5, 2025
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)
Wim A Wuyts, Luca Richeldi, Shervin Assassi, et al.
The Journal of Allergy and Clinical Immunology
|
February 3, 2016
Variants near the HLA complex group 22 gene (HCG22) confer increased susceptibility to late-onset asthma in Japanese populations
Yohei Yatagai, Tomomitsu Hirota, Tohru Sakamoto, et al.
The European Respiratory Journal
|
August 7, 2025
Pulmonary Sarcoidosis Clinical Trial Endpoints: A Delphi Study
Robert P Baughman, Jan C Grutters, Elyse E Lower, et al.
The New England Journal of Medicine
|
May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
Toby M Maher, Shervin Assassi, Arata Azuma, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 16, 2015
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, et al.
The Lancet. Respiratory Medicine
|
January 7, 2021
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
Kristin B Highland, Oliver Distler, Masataka Kuwana, et al.
ERJ Open Research
|
June 5, 2020
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan
Yuji Minegishi, Akihiko Gemma, Sakae Homma, et al.
The New England Journal of Medicine
|
May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
Luca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
Respiratory Investigation
|
March 1, 2021
The Japanese respiratory society guidelines for the management of cough and sputum (digest edition)
Hiroshi Mukae, Takeshi Kaneko, Yasushi Obase, et al.
Respiratory Research
|
July 25, 2016
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study)
Takekazu Iwata, Ichiro Yoshino, Shigetoshi Yoshida, et al.
Page
of 23